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Background: Osterix and Runx2 are master genes that transcriptionally promote osteoblast differentiation.
Results: Osterix and Runx2 cooperate to induce osteogenic genes by binding to promoters and interacting with each other.
Conclusion: Osterix and Runx2 exhibit cooperation, subject to further regulation by MAPK signals, during osteogenesis.
Significance: A network of interactions between transcription factors provides a circuit that drives the osteoblast differentiation
program.
The transcription factors Runx2 and Osx (Osterix) are re-
quired for osteoblast differentiation and bone formation. Runx2
expression occurs at early stages of osteochondroprogenitor
determination, followed by Osx induction during osteoblast
maturation. We demonstrate that coexpression of Osx and
Runx2 leads to cooperative induction of expression of the osteo-
genic genes Col1a1, Fmod, and Ibsp. Functional interaction of
Osx and Runx2 in the regulation of these promoters is mediated
by enhancer regions with adjacent Sp1 and Runx2 DNA-binding
sites. These enhancers allow formation of a cooperative tran-
scriptional complex, mediated by the binding of Osx and Runx2
to their specific DNA promoter sequences and by the protein-
protein interactions between them. We also identified the
domains involved in the interaction between Osx and Runx2.
These regions contain the amino acids in Osx and Runx2
known to be phosphorylated by p38 and ERK MAPKs. Inhi-
bition of p38 and ERK kinase activities or mutation of their
known phosphorylation sites in Osx or Runx2 strongly dis-
rupts their physical interaction and cooperative transcrip-
tional effects. Altogether, our results provide a molecular
description of a mechanism for Osx and Runx2 transcrip-
tional cooperation that is subject to further regulation by
MAPK-activating signals during osteogenesis.
Bone development and remodeling depend on the activity of
the osteoblasts that derive from condensations of mesenchymal
stem cells. It is well known that osteochondroprogenitor mat-
uration and the later conversion of preosteoblasts to mature
osteoblasts are controlled by a complex network of transcrip-
tion factors activated by specific osteogenic signals. Among
these transcription factors, Runx2 and Osx (Osterix) play a crit-
ical role in osteogenesis (1–3). They are considered master
osteogenic factors because their null mice do not form mature
osteoblasts (4, 5). In Osx-null mice, bone calcification is pre-
vented, even though Runx2 is expressed, suggesting that Osx
acts downstream of Runx2 during bone development (5).
Moreover, in adult organisms, osteoblast action is still required
because the mammalian skeleton undergoes continuous turn-
over throughout the lifetime. In vivo studies have demonstrated
that Runx2 and Osx are mandatory for osteoblast maturation as
well as bone formation during the adult stage (4, 6, 7). In addi-
tion, several Runx2 and Osx mutations or SNPs are related to
bone illnesses such as osteoporosis, osteogenesis imperfecta,
and cleidocranial dysplasia (8 –12).
Several studies have highlighted the role of Runx2 and Osx in
osteoblast function at the molecular level. It has been demon-
strated that expression of Osx in vivo requires Runx2, although
osteogenic signals are still able to stimulate Osx expression in
Runx2-deficient cells (13–17). Runx2 regulates the expression
of numerous osteoblastic genes such as Osx, Alpl (alkaline
phosphatase), Col1a1 (collagen type I), Spp1 (osteopontin),
Ibsp (bone sialoprotein), Mmp13 (matrix metalloproteinase
13), and Bglap (osteocalcin) (4, 18, 19). Most of these gene pro-
moters are also regulated by Osx (5, 19 –22), and in fact, Osx is
able to direct its own expression (17). Promoters of several
osteoblast-specific genes contain both Runx2-binding sites
(TGTGGT) and Sp1 boxes (which are bound by Osx). Thus, it is
plausible that Runx2 and Osx work in a collaborative manner to
activate the osteoblast genetic program and produce a bone-
specific matrix. This hypothesis is supported by the described
interaction between Runx2 and Osx in the transcriptional reg-
ulation of Mmp13 and Col1a1 genes (19, 21). Conversely, in the
regulation of Nell-1 expression, Osx and Runx2 seem to play
opposite roles, as the former represses the expression of this
gene, and the latter activates it (23).
In the control of downstream events, the master function of
Runx2 has also been shown to be tightly regulated by interac-
tion with cofactors. For instance, interaction with Stat1 inhibits
its nuclear localization, and interaction with Twist1, Nrf2, or
COUP-TFII (chicken ovalbumin upstream promoter transcrip-
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tion factor II) blocks Runx2 DNA-binding ability (20, 24, 25).
Positive coactivation of Runx2 has been described for Smad,
TAZ, Dlx5, or Gli family members (26 –30). In turn, Osx also
collaborates with other transcription factors and cofactors such
as Sp1, NFATc1, and NO66, which regulate its activity (1, 22,
31). NFATc1 forms a complex with Osx and activates Col1a1
promoter activity, but it does not activate Runx2-dependent
transcription (31). These studies evidence a complex cross-talk
between these transcription factors and the transcriptional
machinery but also highlight that our knowledge of their regu-
latory mechanisms is limited.
Recent work has expanded our understanding of the role of
p38 and ERK MAPKs in the control of osteogenesis and, in
particular, their regulation of Runx2 and Osx transcriptional
activity (32). Induction of Osx expression requires the activa-
tion of Dlx5 through p38-mediated phosphorylation (16). Fur-
thermore, it has been shown that Osx itself is a substrate for p38
(33) and ERK MAPK (34, 35), which increases recruitment of
transcriptional coactivators (33). Similarly, Runx2 is strongly
regulated through direct p38 and ERK MAPK phosphorylation.
Phosphorylation of Runx2 at multiple sites leads to increased
transcriptional activity. Thus, a regulatory network exists in
which p38 and ERK MAPK phosphorylation is involved in
the induction and control of Runx2 and Osx transcriptional
activity.
Here, we report functional cooperation between Osx and
Runx2 modulating the expression of osteoblast genes Col1a1,
Fmod (fibromodulin), and Ibsp, which are involved in the for-
mation of a mature bone matrix. Induction of these genes is
mediated through enhancer regions encompassing nearby Sp1
sites and Runx2 DNA-binding sites. Formation of a cooperative
complex is mediated through DNA binding of Runx2 and Osx
to their cognate sequences as well as protein-protein interac-
tions between them. Moreover, we demonstrate that their
phosphorylation by p38 and/or ERK MAPK at specific sites is
required for efficient interaction and cooperation.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—C2C12, Saos-2, and HEK-
293T cell lines (American Type Culture Collection, Manassas,
VA) were maintained in DMEM supplemented with 10% FBS,
0.2 mM glutamine, 0.1 mM pyruvate, and 100 units/ml penicil-
lin/streptomycin. MC3T3-E1 preosteoblasts (American Type
Culture Collection) were maintained in -minimal essential
medium supplemented with 10% FBS, 0.2 mM glutamine, 0.1
mM pyruvate, and 100 units/ml penicillin/streptomycin. Pri-
mary osteoblasts were seeded in culture after collagenase diges-
tion of calvariae from P1–P4 mouse pups. Bones were dissected
from euthanized pups, and their sutures and soft tissue were
discarded. 8 –12 calvariae were pooled and serially digested in a
trypsin (0.025%)/collagenase II (1 mg/ml) solution. The prod-
uct of the first 5 min of digestion was discarded, and the product
of a double 40-min digestion was centrifuged (400  g, 5 min)
and seeded on 60-mm culture plates. Mouse primary osteo-
blasts were maintained in -minimal essential medium supple-
mented with 10% FBS, 0.2 mM glutamine, 0.1 mM pyruvate, 100
units/ml penicillin/streptomycin, 50 M ascorbic acid, and 5
mM -glycerophosphate. C2C12, MC3T3-E1, and Saos-2 cells
were transiently transfected using Lipofectamine LTX (Invitro-
gen). HEK-293T cells were transiently transfected using
polyethylenimine.
Plasmids and Reagents—Osx expression vectors were kindly
provided by Dr. B. de Crombrugghe. The Ibsp-plux and
2483pCol1a1-lux reporters were generated by PCR, and
2483pCol1a11 and 2483pCol1a12 were generated by
restriction of 2483pCol1a1-lux (21). OC-p147-lux was a gift
from Dr. G. Karsenty. The Sp1-plux reporter was a gift from Dr.
C. Caelles. Point mutations in the Runx2 and Sp1 sites of Ibsp-
plux and deletions in the OC-p147-lux reporter were generated
by PCR. The Ibsp enhancer was amplified by PCR with the
mutant-specific primers 5-agaaagagcaattctggcttctcttgggt to
mutate the distal Runx2 site, 5-agaaagagcaattctggcttctcttcgct
to mutate the distal Runx2 and Sp1 sites, and 5-accgcgacgctt-
gatgtaaaacgagacga to mutate the proximal Runx2 and Sp1 sites.
Amplified products were subcloned into pGL2-fos, containing
the minimal c-fos promoter. Deletions and point mutations of
OC-p147-lux were also generated by PCR with the common
reverse primer 5-ttgtcagatctgcaccctccagca, and primers 5-
tgagcacggtacccccaattagtcctggc for OC mut-1, 5-agcacggtaccc-
actattcgtcctggcagcatcacatgctactcc for OC mut-2, and 5-aga-
gatcggagagtagccgatataaatgctac for OC mut-3. Amplified
products were subcloned into pGL-2Basic. GST-Runx2, GST-
Runx2361, and GST-Runx2230 were kindly provided by Dr.
M. Montecino. GST-Osx346 and GST-Osx140 were gener-
ated by digestion with SmaI and double digestion with NotI and
StyI, respectively, from Osx subcloned into the pGEX vector
(33). The Osx(S73A/S77A) mutant expression vector was
generated as described previously (33). Myc-Runx2 and the
Myc-Runx2(S43A/S282A/S319A) mutant were kindly
provided by Dr. L. H. Glimcher. SB203580 and U0126 (Calbio-
chem) were used at final concentrations of 10 and 5 M, respe-
ctively. Antibodies against Osx (Abcam), Runx2 (MBL Inter-
national Corp.), and -tubulin (Sigma) were used at a 1:1000
dilution.
Luciferase Reporter Assays—Saos-2 or C2C12 cells were cul-
tured in 6-well plates and transfected for 8 h with Lipo-
fectamine LTX with the indicated plasmids. The transfection
efficiency was assessed by GFP expression. Luciferase activities
were quantified at 48 h using the Luciferase assay system (Pro-
mega) and normalized using the -Galactosidase Detection Kit
II (Clontech).
GST Pulldown Assays—The fusion proteins GST-Osx and
GST-Runx2 and their derivatives were produced in Escherichia
coli BL21 and purified by binding to glutathione-Sepharose
beads. For in vitro binding assays, cells expressing Osx and/or
Runx2 were washed twice with cold PBS and lysed with 0.3%
CHAPS, 50 mM Tris (pH 7.5), 150 mM NaCl, and 10% glycerol
supplemented with protease and phosphatase inhibitors at 4 °C
for 15 min. Lysates were collected and centrifuged at 22,000 
g for 5 min to eliminate cellular debris. Supernatants were incu-
bated with the appropriate chimeric protein bound to glutathi-
one-Sepharose beads overnight at 4 °C with rotation. The beads
were then collected by centrifugation at 300  g for 1 min and
washed five times with wash buffer (0.1% CHAPS, 50 mM Tris
(pH 8.0), and 150 mM NaCl). Finally, proteins bound to the
beads were subjected to immunoblotting.
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Immunoprecipitation—Primary osteoblasts or transiently
transfected HEK-293 cells were lysed as described above. The
supernatant fraction was incubated overnight with 1 g of anti-
Osx or anti-Runx2 antibody, followed by incubation with 20 l
of Protein A/G-Sepharose (GE Healthcare) for 1 h. Bound pro-
teins were washed four times with lysis buffer and detected by
immunoblotting.
Western Blot Assay—To detect the presence of proteins in
the cell extracts or pulldowns, we performed immunoblotting
with anti-Osx, anti-Runx2, or anti--tubulin antibody diluted
at 1:1000. Immunoreactive bands were detected with horserad-
ish peroxidase-conjugated secondary antibodies using an ECL
kit (Biological Industries).
ChIP—Saos-2 and MC3T3-E1 cells were cultured until con-
fluence and fixed with 1% formaldehyde for 10 min, and the
reaction was stopped with 0.01 M glycine for 5 min. Cells were
lysed and sonicated to obtain 200 –1000-bp fragments. ChIP
was carried out using 1 g of the indicated antibody (anti-Osx,
anti-Runx2, anti-RNA polymerase II (Upstate), or anti-IgG
(Upstate) as a control) and purified with 20 l of Magna ChIP
Protein AG magnetic beads (Millipore). The complexes were
washed once with four different wash buffers and eluted with a
solution containing SDS and NaHCO3. Reversion of cross-link-
ing was carried out by overnight incubation with 0.2 M NaCl at
65 °C, followed by treatment with proteinase K and RNase A.
The DNA fragments were purified using the QIAquick gel
extraction kit (Qiagen) and analyzed by PCR.
The primers used for Saos-2 cells for PCR analysis were as
follows: HsFmod F, 5-ggacccagagctcccaatgtttcaggga; HsFmod
R, 5-cgtccctcgagctggcctccttgggttg; HsIbsp F, 5-cttctttctcatgt-
ggccaacactcg; HsIbsp R, 5-tggcatcaggagatgtcctctctt; HsColBE
F, 5-tgctccagagctgcaaacgtggaagc; HsColBE R, 5-tccattgctgtc-
tccagtcctgcct; HsColProx F, 5-ggttagcccacgccattctgagga; and
HsColProx R, 5-ggaaggggtcggtgtttctcagatg. Those used for
MC3T3-E1 cells were as follows: MmFmod F, 5-ttcaggctgcca-
atgctccagggaa; MmFmod R, 5-tgaccacgtccttctgtctggtct;
MmIbsp F, 5-ccagttttcaaacatccaaatccatagg; MmIbsp R, 5-ttg-
gcactgggagatgtcctccctt; MmColBE F, 5-gaaggcactggggtctcctt-
gcaggg; MmColBE R, 5-tccattgctgtctccagctctgctt; MmColProx
F, 5-tgggtggactcctttcccttccttt; and MmColProx R, 5-ttag-
cttcggctcatgcgtggcctca.
Immunofluorescence—Saos-2 and transfected C2C12 cells
were fixed in 4% paraformaldehyde for 20 min, permeabilized
with 0.2% Triton X-100, and blocked with normal goat serum
for 1 h. Cells were stained with anti-Osx antibody at 1:150 dilu-
tion and anti-Runx2 antibody at 1:100 dilution, followed by
FIGURE 1. Additive effect of Osx and Runx2. C2C12 (A) or MC3T3-E1 (B) cells were cotransfected with Osx and/or Runx2 expression vectors. Col1a1, Fmod, and
Ibsp mRNAs from C2C12 or MC3T3-E1 cells were measured by quantitative RT-PCR and normalized to Gapdh, and relative expression is presented as the
mean  S.E. of nine independent experiments. *, p  0.05; **, p  0.01; ***, p  0.005 using Student’s t test.
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goat anti-rabbit IgG conjugated with Alexa Fluor 555 at 1:500
dilution or anti-mouse IgG conjugated with Alexa Fluor 488.
Nuclei were stained using a 1:1000 dilution of DRAQ5. Labeling
was detected using a Leica TCS SL inverted laser scanning con-
focal microscope.
Quantitative RT-PCR Analysis—Total RNA was isolated
from C2C12 and MC3T3-E1 cells using TRIsure reagent (Bio-
line). 5 g of total RNA was reverse-transcribed using a high
capacity cDNA reverse transcription kit (Applied Biosystems).
Quantitative PCRs were carried out using the ABI Prism 7900
HT Fast real-time PCR system and a TaqMan 5-nuclease
probe method (Applied Biosystems). All transcripts were nor-
malized to Gapdh, and transfection efficiency was assessed by
GFP expression. Designed TaqMan assays (Applied Biosys-
tems) were used to quantify gene expression of mouse Col1a1,
Fmod, Ibsp, Gapdh, and osteocalcin.
Statistical Analysis—Statistical analysis was performed using
Student’s t test. Quantitative data are presented as means  S.E.
Differences were considered significant at p  0.05.
RESULTS
Coexpression of Osx and Runx2 Enhances Transcription of
Osteogenic Genes—The expression of many osteogenic markers
is modulated by Osx and/or Runx2. To determine their relative
relevance, we transfected C2C12 and MC3T3-E1 cell lines with
Osx and/or Runx2 expression vectors. As reported previously
(21, 33), quantitative RT-PCR assays demonstrated that over-
expression of Osx or Runx2 in C2C12 cells can up-regulate the
endogenous expression of collagen type 1 (Col1a1), fibromodu-
lin (Fmod), and bone sialoprotein (Ibsp) (Fig. 1A). This effect
was also observed in MC3T3-E1 preosteoblasts, where Col1a1,
Fmod, and Ibsp expression was enhanced when Osx was over-
expressed (Fig. 1B). More importantly, in both cell lines, coex-
pression of Osx and Runx2 had a strong additive effect in the
expression of these osteogenic genes. To further analyze the
mechanism of this cooperation, we focused on the presence of
Runx2- or Osx-binding sites in the promoter sequences of these
genes. Homology analysis of Ibsp, Fmod, and Col1a1 gene pro-
FIGURE 2. Cooperative transcriptional activation by Runx2 and Osx DNA binding. C2C12 or Saos-2 cells were cotransfected with Osx and/or Runx2
constructs and the indicated reporters. Schemes of Ibsp-plux (A), OC-p147-lux (Bglap reporter) (B, upper panel), and Sp1-plux (B, lower panel) reporter vectors
are shown. Luciferase activity was measured and normalized against -galactosidase activity. * and #, p  0.05; **, p  0.01; ***, p  0.005.
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moters revealed regions with a high degree of similarity among
orthologs, which include one or more Runx2 sites in close prox-
imity to Sp1 sites (Fig. 2). For instance, the study of a distal
enhancer of the Ibsp gene revealed the presence of two Runx2-
binding sites close to an Sp1 site bound by Osx (Fig. 2A) (33).
We evaluated the Ibsp promoter activity in C2C12 cells and in
the osteosarcoma cell line Saos-2 using a luciferase reporter
driven by the Ibsp enhancer (33). Although expression of Runx2
had minor effects on promoter activity in C2C12 cells, we
observed a 20-fold induction of Ibsp-plux activity in response to
Osx and 	40-fold induction when both Osx and Runx2 were
coexpressed (Fig. 2A). This cooperative induction of the Ibsp
reporter was similar when analyzed in Saos-2 cells. Thus, these
results indicate that Osx and Runx2 have cooperative effects on
specific gene expression.
Next, we assessed the importance of the specific cis-respon-
sive sequences in the cooperative effects between Runx2 and
Osx. The OC-p147-lux reporter is driven by the proximal Bglap
promoter and contains two Runx2-binding sites and two Sp1
sites (Fig. 2B, left panel). As described previously (36), overex-
FIGURE 3. Requirement for Runx2- and Sp1-binding sites in cooperative activation. A, C2C12 cells were cotransfected overnight with Osx and/or Runx2
constructs and the indicated Col1a1 reporters. A scheme is shown in the lower panel. Basal activities refer to those of the 2483pCol1a1-lux reporter. Luciferase
activity was measured and normalized against -galactosidase activity. B, C2C12 or Saos-2 cells were cotransfected with Osx and/or Runx2 constructs and the
indicated Ibsp-lux reporters. Schemes of the mutated sites introduced in the Ibsp-lux reporter vector are shown. Luciferase activity was measured and
normalized against -galactosidase activity. C, C2C12 or Saos-2 cells were cotransfected with Osx and/or Runx2 constructs and the indicated OC-p147-lux
reporters. Schemes of the deleted and mutated sites in the OC-p147-lux reporter vector are shown. Luciferase activity was measured and normalized against
-galactosidase activity. Relative luciferase activities are expressed as the mean  S.E. in triplicate of four independent experiments. #, p  0.05; ** and ##, p 
0.01; *** and ###, p  0.005 using Student’s t test.
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pression of Runx2 induced OC-p147-lux reporter activity (Fig.
2B). It has also been reported that although Osx binds to these
Sp1 sites, it is unable to induce significant transcriptional acti-
vation (22). Our data showed that Osx expression conferred
additive effects on Runx2 activation, which were more evident
in the Saos-2 osteoblastic cells than in the C2C12 mesenchymal
cell line (Fig. 2B). To further test the relevance of specific bind-
ing sites, we analyzed the activity of the Sp1-plux reporter, an
artificial promoter containing a unique Sp1 site (Fig. 2B, left
panel). The reporter was activated 2-fold by Osx expression.
However, coexpression of Runx2 failed to induce significant
additive transcriptional effects (Fig. 2B).
We also analyzed a pCol1a1-lux reporter, which contains
functional Runx2-binding boxes and Sp1 sites (Fig. 3A, lower
panel) (18, 37). The 2483pCol1a1-lux reporter was activated
by Osx and Runx2, and the coexpression of both factors also nota-
bly increased its induction. Furthermore, the 2483pCol1a11-
lux reporter, devoid of Runx2-binding sites, lost cooperativity
between the two factors, as shown above with the Sp1-plux
reporter. In the 2483pCol1a12-lux reporter, the proximal
region is intact, and although it still maintains a single Runx2
binding site, we did not observe the additive effects, suggesting
that this proximal Runx2 site may be less important for these
effects. This result is in agreement with previous reports that
FIGURE 4. Osx and Runx2 physically interact and associate with the same promoter region. A, ChIP analysis was performed in MC3T3-E1 and Saos-2 cells
by incubation of DNA-protein complexes with antibodies against Osx, Runx2, RNA polymerase (pol) II, and IgG as a negative control. Primers specific for the Ibsp
and Fmod enhancers, the Col1a1 bone enhancer (ColBE), and the Col1a1 proximal promoter (ColProx) were used for PCR analysis. Extracts of HEK-293T cells
expressing Runx2 (B) or Osx (C) were incubated overnight with the indicated chimeric proteins bound to glutathione-Sepharose beads. Interacting proteins
were identified by immunoblotting using anti-Runx2 or anti-Osx antibody. PST, Pro/Ser/Thr-rich.
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Runx2 bound only weakly and did not transactivate the Col1a1
promoter from this 372 proximal Runx2 site (18). Moreover,
we generated a set of Ibsp and OC-p147 reporter constructs
with mutations at specific Runx2 and Sp1 sites. Mutation of the
distal Runx2 site in the Ibsp enhancer did not abolish the addi-
tive effects of Runx2 and Osx. However, mutation of either the
Sp1 or proximal Runx2 sites suppressed activation by Runx2
and/or Osx (Fig. 3B). Similarly, deletion of the most distal
Runx2 site in the osteocalcin promoter completely eliminated
transcriptional activation by Runx2 or Osx (Fig. 3C). Alto-
gether, these results suggest that gene promoters activated
cooperatively by Osx and Runx2 require the presence of adja-
cent Runx2- and Osx-binding sites.
To confirm that functional interaction between Osx and
Runx2 occurs in vivo, ChIP was performed in Saos-2 and
MC3T3-E1 cells. As shown in Fig. 4A, both Osx and Runx2
bound to the responsive regions of the osteogenic genes Fmod,
Ibsp, and Col1a1. Binding of these factors also correlated with
recruitment of RNA polymerase II.
Osx and Runx2 Physically Interact—The presence of Runx2
sites near Osx sites within the same promoter and the func-
tional interdependence between them raised the possibility that
both factors might associate through physical interaction. To
evaluate this hypothesis, we carried out GST pulldown analy-
ses. HEK-293T cells were transiently transfected with Osx or
Runx2 expression vectors and processed with different lysis
buffers. Extracts lysed with isotonic buffers containing 0.5%
Triton X-100, 0.5% Nonidet P-40, or 0.3% CHAPS were tested.
We analyzed the ability of Runx2 or Osx to interact with full-
length recombinant GST-Osx or GST-Runx2 and truncated
forms in vitro. High affinity interaction was maximally retained
with the 0.3% CHAPS lysis buffer (data not shown). Using the
same approach, we determined which domains of Osx and
Runx2 were involved. After Osx pulldown, we found that
Runx2 was able to interact with the truncated forms of Osx.
Osx346 precipitated higher amounts of Runx2 (Fig. 4B), so we
concluded that Osx interacted mainly through its N-terminal
transactivation domain and that the zinc fingers were not
involved. In contrast, whereas Runx2 with a carboxyl-terminal
deletion to amino acid 361 still bound Osx, recombinant Runx2
in which amino acids 230 –521 had been deleted lost most of its
capacity to interact with Osx (Fig. 4C). region 230 –361 did not
encompass the Runt DNA-binding domain of Runx2 and has
also been demonstrated to be involved in interaction with other
proteins such as the vitamin D receptor and with histone acetyl-
transferases MORF and MOZ (38, 39). Interaction between
Osx and Runx2 was also observed in intact cells. Immunopre-
cipitation of Osx from transiently transfected C2C12 cell
extracts also coprecipitated Runx2 (Fig. 5A), further suggesting
interaction between these transcription factors in vivo.
Regions involved in mutual interaction include the known
nuclear localization signals for both Osx and Runx2. Moreover,
because it has been demonstrated previously that some Runx2
interactors modify the nuclear or subnuclear localization of
Runx2 (40, 41), we analyzed the localization of these two tran-
scription factors by immunofluorescence (Fig. 5B). Expression
of either Runx2 or Osx alone displayed a constitutive nuclear
localization for both. Coexpression of both factors did not alter
their nuclear pattern of localization, suggesting that changes in
their nuclear shuttling are not the mechanism involved in their
functional interaction.
p38 and ERK MAPK Activities Are Necessary for Functional
and Physical Interaction between Runx2 and Osx—The activi-
ties of ERK and p38 MAPKs have been shown to phosphorylate
and increase the transcriptional activities of Runx2 and Osx (6,
32–34, 42) Moreover, the MAPK phosphorylation sites in Osx
and Runx2 identified so far are localized within the regions
described above as being involved in their physical interaction
(33, 42, 43). Therefore, we tested the effect of the phosphory-
lation state of Osx and Runx2 on their transcriptional coopera-
tion. We coexpressed Osx and Runx2 in C2C12 cells and
treated them with the p38/ inhibitor SB203580 or the
ERK1/2 inhibitor U0126. These inhibitors are known to block
phosphorylation of either Runx2 or Osx (33, 43). mRNA
expression analysis of Col1a1, Fmod, Ibsp, and Bglap demon-
strated that inhibition of p38 or ERK signaling resulted in com-
plete abrogation of Osx and Runx2 additive effects in all genes
studied (Fig. 6A). We also performed similar studies using the
2483pCol1a1-lux, Ibsp-plux, and OC-p147-lux gene report-
FIGURE 5. In vivo interaction of Osx and Runx2 is restricted to the nucleus.
A, C2C12 cells were transfected with Runx2 and/or Osx expression vectors.
Expression of the constructs and anti-Osx-co-immunoprecipitated proteins
was analyzed by immunoblotting. B, the subcellular localization of Runx2 and
Osx was analyzed by immunofluorescence with anti-Runx2 or anti-Osx anti-
body in C2C12 cells transiently transfected with Runx2 and/or Osx expression
vectors. IP, immunoprecipitated.
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ers. Luciferase assays showed strong and consistent inhibition
of reporter activity upon addition of inhibitors (Fig. 6B).
The results indicate that functional cooperation between the
two transcription factors may be compromised because their
phosphorylation is necessary for complete activity. However,
these results did not discern whether phosphorylation hampers
the interaction between the transcription factors or whether it
is required only for the independent recruitment and function
of transcriptional coactivators for each one. To further examine
whether protein-protein interaction ability depends on the
phosphorylated state, we carried out a pulldown assay using
full-length GST-Osx and GST-Runx2. Assays performed with
GST-Osx and lysates from C2C12 cells expressing Runx2 dem-
onstrated the importance of the Runx2 phosphorylation state.
The levels of Runx2 bound to Osx were lower in extracts from
cells treated with MAPK inhibitors, despite similar levels of
expression (Fig. 7A, upper panel). A complementary analysis
for the requirement of Osx phosphorylation was also per-
formed. As shown in Fig. 7A (lower panel), the interaction was
also lower when extracts from cells treated with MAPK inhib-
itors were assayed. These data suggest that MAPK phosphory-
lation of both transcription factors is involved in protein inter-
action. We investigated whether inhibition of p38 and ERK
MAPKs affects localization of endogenous Osx and Runx2 in
Saos-2 cells. The addition of SB203580 and U0126 to Saos-2
cells decreased the protein expression levels of both transcrip-
tion factors. However, they did not impair the nuclear co-local-
ization of endogenous Osx or Runx2 (Fig. 7B).
The MAPK requirement for Osx and Runx2 interaction was
confirmed in vivo by immunoprecipitation of C2C12 cell
extracts expressing Runx2 and Osx and treatment with MAPK
inhibitors. Western blot analyses showed a strong decrease in
their interaction when p38 or ERK1/2 MAPK activities were
restrained. Interestingly, although ERK inhibition alone com-
FIGURE 6. Runx2 and Osx phosphorylation effects on cooperative transcriptional activity. A, C2C12 cells were cotransfected with Osx and/or Runx2
expression vectors and treated with SB203580 or U0126 for 24 h. Col1a1, Fmod, osteocalcin (Bglap), and Ibsp mRNAs were measured by quantitative RT-PCR and
normalized to Gapdh, and relative expression is presented as the mean  S.E. of four independent experiments. B, C2C12 cells were mock-transfected or
cotransfected with Osx and/or Runx2 constructs and the indicated reporters. Cells were treated with SB203580 or U0126 for 24 h. Luciferase activity was
measured and normalized against -galactosidase activity. Relative luciferase activities are expressed as the mean  S.E. in triplicate of at least three inde-
pendent experiments. * and #, p  0.05; **, p  0.01 using Student’s t test).
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pletely blocked interaction, cells in which p38 MAPK activity
was blocked still retained some interaction (Fig. 8A). However,
because inhibition of one MAPK usually results in activation of
the other, it is too early to make definitive conclusions about
differences in p38 and ERK MAPK requirements.
We further characterized the interaction between endoge-
nous Runx2 and Osx in primary cultures of mouse calvarial
osteoblasts treated with SB203580, U0126, or both inhibitors.
As reported previously (16, 21, 42, 44), Runx2 and Osx protein
levels were decreased after MAPK inhibition by either
SB203580 or U0126 treatment. More importantly, the amount
of Runx2 that coprecipitated bound to Osx was significantly
decreased by the simultaneous inhibition of both MAPKs (Fig.
8B). Together, these results indicate that both MAPK activities
are required for a proper physical and functional interaction
between these two transcription factors.
MAPK Phosphorylation Sites Are Involved in the Osx-Runx2
Interaction—Previous studies have shown that ERK interacts
through a D-domain-docking site and phosphorylates Runx2 at
four sites (Ser-43, Ser-301, Ser-319, and Ser-510) (6, 32, 44, 45).
Among them, Ser-301 and Ser-319 both contribute to Runx2
function because Ser-to-Ala mutations at these sites greatly
reduce its transcriptional activity at specific osteogenic pro-
moters (6). Interestingly, these two sites have also been shown
to be phosphorylated by the p38 pathway and are located in the
Osx-Runx2 interaction region (Fig. 4) (42). In contrast, Osx is
also phosphorylated by p38 at Ser-73 and Ser-77, located in the
transactivation domain, which also has a positive effect on its
osteogenic activity (21, 33). We then sought to ascertain the
importance of the specific phosphorylation sites of these pro-
teins in functional cooperation. We analyzed the interaction in
vivo by expressing combinations of wild-type Osx and mutant
S73A/S77A with wild-type Runx2 and mutant S43A/S282A/
S319A. Immunoprecipitation analysis demonstrated that
combinations expressing a phosphorylation-deficient mu-
tant form (either Osx(S73A/S77A) or Runx(S43A/S282A/
S319A)) showed impaired interaction (Fig. 8C). These results
prove that the phosphorylation sites targeted by p38 and ERK
MAPKs in both Osx and Runx2 are the ones involved in the
Osx-Runx2 interaction.
DISCUSSION
It is physiologically and clinically important to understand
the mechanisms of the transcriptional network that drives
osteoblastogenesis. In this study, we have shown that the key
osteogenic transcription factors Runx2 and Osx cooperate in
the induction of genes involved in bone matrix formation.
Transcriptional activation of these promoters is mediated
through enhancer regions encompassing nearby Sp1 and
Runx2 DNA-binding sites. Our study shows that both Runx2
and Osx bind to their responsive regions in DNA and interact
with each other through the Osx N-terminal transactivation
region and the Runx2 Pro/Ser/Thr-rich activation domain.
Therefore, the two transcription factors form a complex at spe-
cific promoters that increases expression of osteogenic genes
such as Bglap, Col1a1, Fmod, and Ibsp. In addition, we demon-
strated that Runx2 and Osx phosphorylation by p38 and/or
ERK MAPK at specific sites located on their interaction sur-
faces is required for an efficient interaction between them.
Runx2 is expressed as early as embryonic day 10 in develop-
ing mouse embryos, and Osx appears at embryonic day 18.5
(4, 5). The Runx2-expressing osteochondroprecursors, prior to
Osx expression, remain in the chondrogenic lineage and
express high levels of Sox9 (5). Later, cells already expressing
Runx2 and Osx differentiate into mature osteoblasts in which
Sox9 is no longer expressed (1). Thus, it may be suggested that
their sequential expression constitutes a mechanism of osteo-
blast maturation in which, once expressed, Osx controls further
transcription independently of Runx2. For instance, in Osx-null
embryos, there is a strong reduction of Col1a1 expression and
an almost complete lack of late osteogenic markers, including
osteonectin, osteopontin, Ibsp, and Bglap, despite normal
expression of Runx2 (1, 5, 6). It may also be suggested that
Runx2 and Osx regulate distinct subsets of osteogenic genes or,
alternatively, act as allies to cooperatively promote maximal
levels of osteogenic gene expression. Our data point to the latter
hypothesis, in which Runx2 and Osx are cofactors in the same
complex, up-regulating specific osteogenic target genes when
they co-occupy their promoters.
The presence of Osx and its association could prevent Runx2
repression by liberating it from factors that prevent Runx2
binding to the DNA. For instance, Twist1, Stat1, or Nrf2 inhib-
FIGURE 7. Runx2 and Osx MAPK phosphorylation is involved in protein
interaction. A, C2C12 cells were transiently transfected with Runx2 or Osx
expression vectors and treated with SB203580 (SB) and U0126 for 24 h.
Extracts were incubated with the indicated chimeric proteins bound to glu-
tathione-Sepharose beads. Expression of the constructs and interacting pro-
teins was identified by immunoblotting using anti-Runx2 or anti-Osx anti-
body. B, Saos-2 cells were incubated in medium without serum and treated
with SB203580 and U0126 for 24 h. The subcellular localization of endoge-
nous Runx2 and Osx was analyzed by immunofluorescence with anti-Runx2
or anti-Osx antibody.
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its Runx2 transcriptional activity by docking to the Runt
DNA-binding domain of Runx2 (24, 25, 41). In osteochondro-
progenitors, it has been proven that expression of Sox9 also
down-regulates Runx2 transcriptional activity (46, 47). Con-
versely, some transcription factors such as Dlx5, Gli, and Smad
also interact with Runx2 but increase its transcriptional activity
(27–30). In these cases, interactions involve domains other than
the Runt DNA-binding domain. Although much less is known
about Osx, it has been found that additional factors such as Sp1
and NFATc1 are required for functional activity on the Bglap or
FIGURE 8. MAPK activities are required for a proper physical interaction. A, C2C12 cells were transiently transfected with Runx2 or Osx expression vectors
and treated with SB203580 and/or U0126 for 24 h. Expression of the constructs and anti-Runx2-co-immunoprecipitated proteins was analyzed by immuno-
blotting. B, primary cultures of mouse calvarial osteoblasts were treated SB203580, U0126, or both for 24 h. Endogenous levels of Runx2, Osx, and anti-Osx-
co-immunoprecipitated proteins were analyzed by immunoblotting. C, C2C12 cells were transiently transfected with the indicated expression vectors and
immunoprecipitated (IP) with anti-Runx2 antibody. Expression of the constructs and co-immunoprecipitated proteins was analyzed by immunoblotting. The
relative levels of immunoprecipitated Osx for each condition are expressed below the panel as the mean  S.E. of at least three independent experiments. **,
p  0.01; ***, p  0.005 using Student’s t test. S2A, S73A/S77A; S3A, S43A/S282A/S319A.
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Col1a1 promoter (22, 31). It has been documented that Runx2
changes its promoter-binding patterns during osteoblastogen-
esis (24). This study demonstrates that whereas the recruitment
of Runx2 to a cluster of genes involved in general cell functions
does not change throughout osteoblast maturation, its binding
to osteoblast-specific gene promoters increases as osteoblast
differentiation progresses. The Mmp13, Fmod, Ibsp, and
Col1a1 gene promoters include one or more Runx2 sites in
close proximity (100 –200 bp) to Sp1 sites (18, 21, 22, 24, 33, 36).
Thus, it is likely that osteogenic genes containing adjacent
Runx2 and Osx sites are regulated in a similar fashion. These
results are consistent with data reported by Lee and co-workers
(34) showing cooperation of Osx and Runx2 in the regulation of
osteogenic marker genes during differentiation of adipose stem
cells into osteoblasts.
Our results show that the region of Runx2 required for Osx
interaction is amino acids 230 –361. This region does not
involve the Runt DNA-binding domain and partially overlaps
with the Pro/Ser/Thr-rich activation domain, which is a trans-
activation domain in Runt-related proteins (48) targeted by
proteins such as MOZ, MORF, and the vitamin D receptor (38,
39). The Runt domain is responsible for Runx2 binding to chro-
matin and, as mentioned above, is targeted by many Runx2
repressors, including Twist1, Elf1, COUP-TFII, and Stat1,
which prevent Runx2 from binding to DNA (20, 24, 41, 49). Our
results show that Osx associates with Runx2 through its N-ter-
minal region and that the zinc fingers are not required. There-
fore, in the Runx2 and Osx cooperative mechanism, both
Runx2 and Osx are able to bind to their responsive sequences
on the promoters and interact with each other via regulatory
regions that lead to stabilization of the transcriptional complex.
This physical interaction between Runx2 and Osx was previ-
ously suggested in the regulation of Mmp13 (19). Runx2 tran-
scription involves interaction with coactivators such p300,
MOZ, and MORF (39, 50). Osx also associates with other tran-
scription factors and cofactors such as Brg1, p300, and NO66,
which regulate its activity (1, 22, 31). Binding and interaction of
both Runx2 and Osx may then also potentiate the recruitment
of these coactivators and the function of the transcriptional
machinery.
ERK and p38 MAPKs are known to be induced by various
stimuli in osteoblasts and play an important role in several steps
of osteoblast lineage progression in vitro and in vivo (6, 42,
51–53). Their effects have been attributed in part to their ability
to phosphorylate Osx and Runx2 (6, 33, 42, 43). MAPK phos-
phorylation of Osx at Ser-73 and Ser-77 does not change its
affinity for binding to the Sp1 sequences analyzed but increases
its ability to recruit coactivators (33). Runx2 is also a substrate
of phosphorylation by ERK and p38 MAPKs, leading to
enhanced transcription and recruitment of transcriptional acti-
vators (6, 32, 42, 43). In addition, Runx2 contains a consensus
MAPK-docking D-site, which allows competitive binding of
ERK and p38 MAPKs (43). Binding to this D-site permits phos-
phorylation of Runx2 by MAPK and is probably also involved in
the phosphorylation of Osx when bound together. More impor-
tantly, the phosphorylation sites of these two kinases corre-
spond to the amino acids located in the interaction surfaces of
both Runx2 and Osx (Ser-301 and Ser-319 for Runx2 and
Ser-73 and Ser-77 for Osx). Accordingly, we demonstrated that
the phosphorylation by p38 and/or ERK MAPK at these specific
sites is required for an efficient interaction and cooperation.
Therefore, in addition to their effects on each transcription
factor alone, MAPK phosphorylations may modify the osteo-
genic activity of Runx2 and Osx, enhancing their ability to
interact with each other. Phosphorylation of Runx2 and Osx by
p38 and ERK signaling would then constitute an integration
point at which extracellular stimuli lead to strong modulation
of their transcriptional activity and control the osteoblastic
phenotype.
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